Back
Akoya Biosciences Vs. Madrigal Pharmaceuticals Industry Stock Comparison
Sell
5
AKYA
Akoya Biosciences
Last Price:
$2.45
Seasonality Move:
-14.25%
Sell
43
MDGL
Madrigal Pharmaceuticals
Last Price:
$314.52
Seasonality Move:
-6.73%
Sell
5
Akoya Biosciences (AKYA)
is a Sell
Is Akoya Biosciences a Buy, Sell or Hold?
-
The current Akoya Biosciences [AKYA] share price is $2.29. The Score for AKYA is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
-
AKYA is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
43
Madrigal Pharmaceuticals (MDGL)
is a Sell
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
-
The current Madrigal Pharmaceuticals [MDGL] share price is $308.57. The Score for MDGL is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
MDGL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AKYA Stock Price Chart
What is Akoya Biosciences's stock price today?
-
The Akoya Biosciences share price today is $2.29The current trend is relatively stagnant and AKYA is experiencing selling pressure, which indicates risk of future bearish movement.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $308.57Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing slight selling pressure.
AKYA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 44.32 | Sell |
Chaikin Money Flow: | -52440 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.17 - 2.47) | Sell |
Bollinger Bands (100): | (2.27 - 2.95) | Sell |
MDGL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.27 | Buy |
Relative Strength Index (14 RSI): | 50.25 | Buy |
Chaikin Money Flow: | -80744 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (302.71 - 326.17) | Sell |
Bollinger Bands (100): | (219.66 - 313.6) | Buy |
AKYA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.41 | Sell |
20-day SMA: | 2.36 | Sell |
50-day SMA: | 2.55 | Sell |
200-day SMA: | 2.86 | Sell |
8-day EMA: | 2.38 | Sell |
20-day EMA: | 2.4 | Sell |
50-day EMA: | 2.49 | Sell |
200-day EMA: | 3.07 | Sell |
MDGL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 309.04 | Sell |
20-day SMA: | 310.05 | Sell |
50-day SMA: | 300.58 | Buy |
200-day SMA: | 258.83 | Buy |
8-day EMA: | 309.83 | Sell |
20-day EMA: | 309.89 | Sell |
50-day EMA: | 298.04 | Buy |
200-day EMA: | 262.08 | Buy |
Akoya Biosciences Earnings Growth & AKYA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.44 per share, and an increase next year of $0.16 per share.
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $4.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $10.27 per share, and an increase next year of $15.85 per share.
Akoya Biosciences Technical Analysis
Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Madrigal Pharmaceuticals Technical Analysis
Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |